Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.51 |
| ▸ | NPY4R | P50391 | 14/20 | 0.43 |
| ▸ | NPY1R | P25929 | 9/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.43 |
| ▸ | NPY2R | P49146 | 5/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | GNPAT | O15228 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29787128 | 0.99 | NOD1 (0.52) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL5598692 | 0.99 | NOD1 (0.52) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL2490761 | 0.99 | NOD1 (0.52) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29697052 | 0.99 | NOD1 (0.52) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31454130 | 0.99 | NOD1 (0.52) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL2811179 | 0.97 | NOD1 (0.51) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| Hydrochloric Acid SCHEMBL9186802 | 0.97 | NOD1 (0.51) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL23286096 | 0.96 | NOD1 (0.50) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1711604 | 0.96 | NOD1 (0.50) | NOD1NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL1711608 | 0.96 | NOD1 (0.50) | NOD1NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255032-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | PROCYTE CORPORATION (US) | 2008-10-16 | — | — | US | disclosed |
| US-7384916-B2 | Methods and compositions for preventing and treating aging or photodamaged skin | PROCYTE CORPORATION (US) | 2008-06-10 | — | — | US | disclosed |
| US-20060246029-A1 | Methods and compositions for preventing and treating aging or photodamaged skin | PROCYTE CORPORATION (US) | 2006-11-02 | — | — | US | disclosed |
| US-20060018851-A1 | Methods and compositions for preventing and treating hyperpigmentation of skin | PROCYTE CORPORATION (US) | 2006-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246029-A1 | Methods and compositions for preventing and treating aging or photodamaged skin | RBP1, RBP4, SOD1 | NOD1 3887/4885NPY4R 3564/4885NPY1R 2475/4885 |
| US-20060018851-A1 | Methods and compositions for preventing and treating hyperpigmentation of skin | RBP1, RBP4, MC1R | NOD1 3746/4885NPY4R 3166/4885NPY1R 1480/4885 |
| US-20080255032-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | RBP1, RBP4, SOD1 | NOD1 3887/4885NPY4R 3564/4885NPY1R 2475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.